SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GZMO

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jeffbas who wrote (5)1/28/1999 8:37:00 AM
From: BWAC  Read Replies (1) of 438
 
I would have to agree 100% with that previous post. Same could be said for GENZL. Maybe even more so. GENZL is also a tracking stock backed by Genzyme. It trades at 3 5/8 and actually has TWO approved products on the market. Epicel for burn victims. Carticel for catilage repair in the knee.

I just don't think Genzyme has done a very good job of marketing these tracking stocks well. They loaded GENZL down with an overburden of debt and are just now changing some of that agreement. It might have been assumed that GZMO would endure the same fate.

More importantly. I have come to an interesting thought/conclusion. I think all these internet stocks have sucked the "high risk" money flow and attention away from many of the small biotechs. One day maybe the situation will reverse itself.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext